Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
19.24
-0.37 (-1.89%)
Feb 21, 2025, 4:00 PM EST - Market closed
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $494.95 million as of February 21, 2025. Its market cap has increased by 370.94% in one year.
Market Cap
494.95M
Enterprise Value
290.41M
1-Year Change
370.94%
Ranking
Category
Stock Price
$19.24
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $494.95M, an increase of 109.02%. That is a compound annual growth rate of 8.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 489.00M | 7.43% |
| Dec 31, 2024 | 455.20M | 325.42% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |